Floatz logo

277 assets in Small Cell Lung Carcinoma

Therapeutic assets addressing Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Alisertib
Small Cell Lung Carcinoma
Puma Biotechnology, Inc.P2B (60)
dll3-car-nk cells
Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Docetaxel
Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P3B (60)
Ifinatamab Deruxtecan
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3B (60)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3B (60)
Memantine
Small Cell Lung Carcinoma
NRG OncologyP3B (60)
Memantine Hydrochloride
Small Cell Lung Carcinoma
NRG OncologyP3B (60)
mhb088c for
Small Cell Lung Carcinoma
Qilu Pharmaceutical Co., Ltd.P3B (60)
Nano-Crystalline Megestrol Acetate Suspension
Small Cell Lung Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.P3B (60)
Orm-6151
Small Cell Lung Carcinoma
Bristol-Myers SquibbP2B (60)
Sacituzumab Tirumotecan
Small Cell Lung Carcinoma
Sichuan UniversityP2B (60)
Saruparib
Small Cell Lung Carcinoma
SWOG Cancer Research NetworkP2B (60)
Selinexor
Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Vorolanib
Small Cell Lung Carcinoma
Henan Cancer HospitalP2B (60)
yl201
Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.P3B (60)
zg006
Small Cell Lung Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,LtdP3B (60)
Amrubicin
Small Cell Lung Carcinoma
AbbVieP3B (59)
Fluzoparib
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (59)
Rituximab
Small Cell Lung Carcinoma
Puma Biotechnology, Inc.P2B (59)
Talazoparib
Small Cell Lung Carcinoma
University Health Network, TorontoP2B (59)
Enzalutamide
Small Cell Lung Carcinoma
MacroGenicsP2B (58)
Nintedanib
Small Cell Lung Carcinoma
The Affiliated Hospital of Qingdao UniversityP4B (58)
Palbociclib
Small Cell Lung Carcinoma
Brown UniversityP2B (58)
Pembrolizumab/Vibostolimab Coformulation
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3B (57)
Pumitamig
Small Cell Lung Carcinoma
BioNTech SEP3B (57)
ql1604
Small Cell Lung Carcinoma
Qilu Pharmaceutical Co., Ltd.P3B (57)
Snb-101
Small Cell Lung Carcinoma
SN BioScienceP1/2B (57)
Trastuzumab
Small Cell Lung Carcinoma
Ascendis Pharma Oncology Division A/SP1/2B (57)
Abbv-706
Small Cell Lung Carcinoma
AbbVieP3B (56)
jk-1201i
Small Cell Lung Carcinoma
JenKem Technology Co., Ltd.P3B (56)
ep0057
Small Cell Lung Carcinoma
Ellipses PharmaP2CCC (55)
Fulvestrant
Small Cell Lung Carcinoma
BeiGeneP2CCC (55)
mk-4830
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP2CCC (55)
Surufatinib
Small Cell Lung Carcinoma
Sun Yat-sen UniversityP2CCC (55)
bl0020
Small Cell Lung Carcinoma
Shanghai Best-Link Bioscience, LLCP1/2CCC (54)
Oxaliplatin
Small Cell Lung Carcinoma
Chongqing University Cancer HospitalP2CCC (54)
pf-08634404
Small Cell Lung Carcinoma
PfizerP2/3CCC (54)
Abiraterone
Small Cell Lung Carcinoma
MacroGenicsP2CCC (53)
abp1011t
Small Cell Lung Carcinoma
Shanghai AB PharmaTech Ltd.P2CCC (53)
Adebelizumab
Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP2CCC (53)
AEX4089DC1
Small Cell Lung Carcinoma
Georgetown UniversityP2CCC (53)
Bemotuzumab
Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (53)
bnt327
Small Cell Lung Carcinoma
BioNTech SEP2CCC (53)
Cediranib
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Dostarlimab
Small Cell Lung Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Envafolimab
Small Cell Lung Carcinoma
Shanghai Chest HospitalP2CCC (53)
FAPI74
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Fingolimod
Small Cell Lung Carcinoma
Medical University of South CarolinaP2CCC (53)
Fluorouracilum
Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1/2CCC (53)
Golidocitinib
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (53)
Showing 51 to 100 of 277 assets
PreviousPage 2 of 6Next